Page last updated: 2024-12-10

prostaglandin e2 ethanolamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

prostaglandin E2 ethanolamide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5283119
CHEMBL ID3398551
CHEBI ID138793
SCHEMBL ID23352505
MeSH IDM0280056

Synonyms (16)

Synonym
pme2
prostaglandin e2-ea
n-(11r,15s-dihydroxy-9-oxo-5z,13e-prostadienoyl)-ethanolamine
LMFA03010151 ,
pge2-ea
prostamide-e2
prostaglandin e2 ethanolamide
CHEBI:138793
194935-38-1
HMS3648F11
CHEMBL3398551
J-012626
SR-01000946419-1
sr-01000946419
dinoprostone ethanolamide
SCHEMBL23352505

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" One group of three normal mice was not dosed (naïve) while another group of three normal mice received a bolus intravenous injection of 50 mg/kg of anandamide."( Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry.
Acheampong, A; Burk, R; Cravatt, BF; Ling, KH; Ni, J; Tang-Liu, DD; Weber, A; Woodward, D, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
prostanoidThe family of natural prostaglandins and prostaglandin-like compounds including prostacyclins and thromboxanes.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1192204Activity at recombinant EP4 receptor (unknown origin) expressed in CHO cells co-expressing Gs protein at 100 nM by electrical cell substrate impedance sensing system2015Bioorganic & medicinal chemistry letters, Mar-15, Volume: 25, Issue:6
Novel tail and head group prostamide probes.
AID1192203Activity at recombinant EP3 receptor (unknown origin) expressed in CHO cells co-expressing Gi protein at 100 nM by electrical cell substrate impedance sensing system2015Bioorganic & medicinal chemistry letters, Mar-15, Volume: 25, Issue:6
Novel tail and head group prostamide probes.
AID1192202Activity at recombinant EP1 receptor (unknown origin) expressed in CHO cells co-expressing Gq protein at 100 nM by electrical cell substrate impedance sensing system2015Bioorganic & medicinal chemistry letters, Mar-15, Volume: 25, Issue:6
Novel tail and head group prostamide probes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (7.14)18.2507
2000's6 (42.86)29.6817
2010's7 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.44 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]